Recently, a case series of three patients with cancer and developed severe polyarthritis following immune blockade therapy, reported successful treatment with tocilizumab (anti-IL-6).35 This reflects a level of commonality between inflammatory and disease resolution mechanisms operating in autoimmune disorders and cancer. The gene discussed is IL6; the disease is polyarticular arthritis.